MASSACHUSETTS EYE AND EAR INFIRMARY
Patent Owner
Stats
- 134 US PATENTS IN FORCE
- 21 US APPLICATIONS PENDING
- Mar 13, 2018 most recent publication
Details
- 134 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 6,288 Total Citation Count
- Dec 30, 1986 Earliest Filing
- 81 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0064,375 AUDITORY STIMULUS FOR AUDITORY REHABILITATIONOct 16, 17Mar 08, 18[G09B, A61B, G06F, A61M]
2018/0043,034 GENE AUGMENTATION THERAPIES FOR INHERITED RETINAL DEGENERATION CAUSED BY MUTATIONS IN THE PRPF31 GENEMar 07, 16Feb 15, 18[A61K, C12N]
2017/0348,384 Treatment of Rhinosinusitis with P-glycoprotein InhibitorsAug 25, 17Dec 07, 17[A61K, A61L]
2017/0314,027 INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTIONAug 06, 15Nov 02, 17[A61K, C12N, C07K]
2017/0043,015 METHODS FOR CROSS-LINKING CORNEAL COLLAGEN WITH VERTEPORFIN FOR THE TREATMENT OF DISORDERS OF THE EYEFeb 26, 15Feb 16, 17[A61K, A61F, A61N]
2017/0020,909 METHODS OF TREATING GLAUCOMA USING AMP-ACTIVATED PROTEIN KINASE (AMPK) ACTIVATORSMar 10, 15Jan 26, 17[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9913854 Methods and compositions for reducing the proliferation of gram positive bacteriaMar 14, 13Mar 13, 18[A61K, A01N, C07D, C09B]
9914782 Methods for preserving the viability of retinal ganglion cells in patients with glaucoma by an anti-TNF receptor 2 (anti-TNFR2) antibodyJul 29, 15Mar 13, 18[A61K, C12N, G01N, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2018/0000,791 METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH ANGIOGENESIS USING A VASCULAR ADHESION PROTEIN-1 (VAP-1) INHIBITORAbandonedFeb 10, 17Jan 04, 18[A61K, C12N, A61N, C07K]
2016/0279,104 METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH ANGIOGENESIS USING A VASCULAR ADHESION PROTEIN-1 (VAP-1) INHIBITORAbandonedNov 09, 15Sep 29, 16[A61K, A61N]
2016/0271,224 METHODS OF REDUCING CORNEAL ENDOTHELIAL CELL LOSSAbandonedNov 20, 14Sep 22, 16[A61K, A61B]
2016/0144,024 Methods and Compositions for Preserving the Viability of Photoreceptor CellsAbandonedJul 29, 15May 26, 16[A61K]
2014/0357,570 COMPOSITIONS COMPRISING NECROSIS INHIBITORS, SUCH AS NECROSTATINS, ALONE OR IN COMBINATION, FOR PROMOTING AXON REGENERATION AND NERVE FUNCTION, THEREBY TREATING CNS DISORDERSAbandonedOct 22, 12Dec 04, 14[A61K]
2014/0178,407 Methods and Compositions for Treating Conditions of the EyeAbandonedJul 23, 13Jun 26, 14[A61K]
2014/0170,160 METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH ANGIOGENESIS USING A VASCULAR ADHESION PROTEIN-1 (VAP-1) INHIBITORAbandonedNov 01, 13Jun 19, 14[A61K, C12N, A61N, C07K]
2014/0163,451 Methods and Compositions for Treating Conditions of the EyeAbandonedAug 12, 13Jun 12, 14[A61K, A61N]
2014/0134,136 COMPOSITIONS AND METHODS FOR AUDITORY THERAPYAbandonedNov 04, 13May 15, 14[C12N, C07K]
2014/0024,598 METHODS AND COMPOSITIONS FOR PRESERVING RETINAL GANGLION CELLSAbandonedOct 21, 11Jan 23, 14[A61K]
2014/0004,510 METHODS AND COMPOSITIONS FOR PROGNOSING AND/OR DETECTING AGE-RELATED MACULAR DEGENERATIONAbandonedSep 23, 11Jan 02, 14[C12Q]
2013/0122,016 Methods and Compositions for Prognosing, Detecting, and Treating Age-Related Macular DegenerationAbandonedJul 09, 12May 16, 13[C12Q]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
